← FDA Drug Approvals (Drugs@FDA)

VINCASAR PFS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 1987-07-17

Drug application

FDA Application #

ANDA071426

Application type

Abbreviated New Drug Application (Generic)

Brand name

VINCASAR PFS

Generic name

Vincristine Sulfate

Active ingredients

VINCRISTINE SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

TEVA PARENTERAL

First approval

1987-07-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown